Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma ; volume:15 ; number:1 ; day:14 ; month:8 ; year:2020 ; pages:1-8 ; date:12.2020
Radiation oncology ; 15, Heft 1 (14.8.2020), 1-8, 12.2020
- Creator
-
Shiba, Shintaro
Shibuya, Kei
Okamoto, Masahiko
Okazaki, Shohei
Komatsu, Shuichiro
Kubota, Yoshiki
Nakano, Takashi
Ohno, Tatsuya
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-020-01634-z
- URN
-
urn:nbn:de:101:1-2020100722202312917463
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shiba, Shintaro
- Shibuya, Kei
- Okamoto, Masahiko
- Okazaki, Shohei
- Komatsu, Shuichiro
- Kubota, Yoshiki
- Nakano, Takashi
- Ohno, Tatsuya
- SpringerLink (Online service)
Other Objects (12)
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer
Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response
Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Biomarkers for Locally Advanced Hepatocellular Carcinoma Patients Treated with Liver-Directed Combined Radiotherapy
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer
Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response
Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Biomarkers for Locally Advanced Hepatocellular Carcinoma Patients Treated with Liver-Directed Combined Radiotherapy
Hypofractionated radiotherapy for prostate cancer
Hypofractionated radiotherapy for localized prostate cancer
A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer
Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
The Role of Hypofractionated Radiotherapy in Prostate Cancer
Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response
Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma